![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Roche Palo Alto, Palo Alto, California
The objective of the present study was to examine the accuracy of using unbound brain concentration determined by a brain homogenate method (Cub), cerebral spinal fluid concentration (CCSF), and unbound plasma concentration (Cup) as a surrogate for brain interstitial fluid concentration determined by brain microdialysis (Cm). Nine compounds—carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental—were selected, and each was administered as an intravenous bolus (up to 5 mg/kg) followed by a constant intravenous infusion (1–9 mg/kg/h) for 6 h in rats. For eight of the nine compounds, the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub. The CCSFs of eight of the nine compounds were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm. The Cups of five of the nine compounds were within 3-fold of their Cm; four compounds (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm. In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compounds tested. The Cups were within 3-fold of Cm for lipophilic non–P-glycoprotein (–P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates. The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concentrations within 3-fold of error in drug discovery and development settings.
This article has been cited by other articles:
![]() |
X. Liu, O. Vilenski, J. Kwan, S. Apparsundaram, and R. Weikert Unbound Brain Concentration Determines Receptor Occupancy: A Correlation of Drug Concentration and Brain Serotonin and Dopamine Reuptake Transporter Occupancy for Eighteen Compounds in Rats Drug Metab. Dispos., July 1, 2009; 37(7): 1548 - 1556. [Abstract] [Full Text] [PDF] |
||||